Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for ARQT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 125.59M
March 31, 2026 125.04M
December 31, 2025 123.33M
September 30, 2025 120.29M
June 30, 2025 119.80M
March 31, 2025 119.14M
December 31, 2024 117.85M
September 30, 2024 117.00M
June 30, 2024 116.48M
March 31, 2024 115.51M
December 31, 2023 96.79M
September 30, 2023 61.86M
June 30, 2023 61.63M
March 31, 2023 61.36M
December 31, 2022 61.04M
September 30, 2022 60.91M
Date Value
June 30, 2022 51.53M
March 31, 2022 51.36M
December 31, 2021 50.26M
September 30, 2021 50.13M
June 30, 2021 50.05M
March 31, 2021 49.89M
December 31, 2020 43.34M
September 30, 2020 37.80M
June 30, 2020 37.69M
March 31, 2020 37.47M
December 31, 2019 38.09M
September 30, 2019 36.24M
June 30, 2019 38.09M
March 31, 2019 38.09M
December 31, 2018 36.24M
September 30, 2018 36.24M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 172.13M
Insmed, Inc. 218.28M
Emergent BioSolutions, Inc. 51.30M
Exelixis, Inc. 248.88M
Vertex Pharmaceuticals, Inc. 253.35M